You have 9 free searches left this month | for more free features.

allogeneic stem cell transplantation in patients with hematological malignancies

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematological Malignancy Trial (Thymoglobulin Injectable Product)

Not yet recruiting
  • Hematological Malignancy
  • Thymoglobulin Injectable Product
  • (no location specified)
Sep 27, 2023

Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

Not yet recruiting
  • Hematological Malignancies
  • Allogeneic T cell progenitors, cultured ex-vivo
  • (no location specified)
Mar 2, 2023

Haematological Malignancy Trial in Nice (6 sessions of adapted physical activity after stem cell transplant)

Recruiting
  • Haematological Malignancy
  • 6 sessions of adapted physical activity after stem cell transplant
  • Nice, France
    CHU NICE, hopital ARCHET 1, hématologie
Jun 13, 2022

Hematopoietic and Lymphoid Cell Tumor Trial in Seattle (Nutritional Supplement Drink, Standard of Care Nutritional Support,

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Nutritional Supplement Drink
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Hematological Malignancies Trial in Durham (fostamatinib)

Active, not recruiting
  • Hematological Malignancies
  • Durham, North Carolina
    Duke University of Medicine
Jul 14, 2022

Hematological Malignancies, CMV Infection Trial in Belgium (CMV-specific T cells, Standard anti-viral therapy)

Completed
  • Hematological Malignancies
  • CMV Infection
  • CMV-specific T cells
  • Standard anti-viral therapy
  • Gent, Oost-Vlaanderen, Belgium
  • +7 more
Dec 19, 2022

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

Recruiting
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 26, 2022

Leukemia, MDS Trial in Duarte (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • fludarabine phosphate
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)

Recruiting
  • Hematological Malignancies
  • Total Body Irradiation
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 4, 2022

Leukemia, MDS Trial (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Feb 17, 2022

Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem

Active, not recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
  • Recipients
  • Donors
  • Paris, France
    Hopital Necker
Nov 19, 2021

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

Active, not recruiting
  • Acute Myelogenous Leukemia
  • +10 more
  • Atlanta, Georgia
  • +2 more
Feb 9, 2022

Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

Recruiting
  • Hematological Neoplasms
  • Recurrence
  • Peg interferon alfa-2b
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

Recruiting
  • Acute Leukemia
  • +27 more
  • HSCT with TBI Regimen
  • HSCT with Non-TBI Regimen
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

Recruiting
  • Hematopoietic Malignancy
  • +2 more
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Nov 6, 2023

Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

Not yet recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023

Hematological Malignancy, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission Trial in New York (Cord blood

Completed
  • Hematological Malignancy
  • +5 more
  • Cord blood stem cells
  • +5 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
May 20, 2021

Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )

Recruiting
  • Hematological Disease
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Feb 6, 2023

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

Completed
  • Leukemia
  • +2 more
  • CliniMACS Fractionation system (Arm A)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 12, 2022

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +5 more
Nov 1, 2022

Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell

Recruiting
  • Hematologic Diseases
  • COVID-19 vaccine(donor)
  • COVID-19 vaccine(patient)
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Nov 8, 2022

Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Malignant Hematological Diseases
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Jul 3, 2023